Showing results (861-870 of 1,163) with videos related to

Sort By:
Pageof 117
Circulation|September 29, 2024
Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF TrialKieran F Docherty, Alasdair D Henderson, Pardeep S Jhund, et al.
European Journal of Heart Failure|March 28, 2023
Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HFDimitrios Farmakis, Jasper Tromp, Smaragdi Marinaki, et al.
JACC. Heart Failure|April 15, 2025
Finerenone and New York Heart Association Functional Class in Heart Failure: The FINEARTS-HF TrialJohn W Ostrominski, Muthiah Vaduganathan, Brian L Claggett, et al.
European Journal of Heart Failure|December 15, 2018
Impact of diabetes and sex in heart failure with reduced ejection fraction patients from the ASIAN-HF registryChanchal Chandramouli, Tiew-Hwa Katherine Teng, Wan Ting Tay, et al.
JACC. Heart Failure|August 26, 2025
Temporal Changes in Biomarkers, Functional Status, and Quality of Life Prior to Adverse Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection FractionHenri Lu, Brian L Claggett, Muthiah Vaduganathan, et al.
Frontiers in Cardiovascular Medicine|May 13, 2022
Insights on Distinct Left Atrial Remodeling Between Atrial Fibrillation and Heart Failure With Preserved Ejection FractionJen-Yuan Kuo, Xuanyi Jin, Jing-Yi Sun, et al.
European Journal of Heart Failure|May 24, 2024
Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trialCarolyn S P Lam, Lars Køber, Koichiro Kuwahara, et al.
ESC Heart Failure|April 12, 2020
Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers studyEiichi Akiyama, Raphaël Cinotti, Kamilė Čerlinskaitė, et al.
JACC. Heart Failure|April 28, 2022
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF TrialMaja Cikes, Ivo Planinc, Brian Claggett, et al.
JAMA Cardiology|March 30, 2025
Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Randomized Clinical TrialAkshay S Desai, Pardeep S Jhund, Muthiah Vaduganathan, et al.
Pageof 117